Fda boxed warning montelukast

Food and Drug Administration (FDA) announced required labeling changes for montelukast (Singulair) to add a boxed warning (BW) (often called a “black box warning”) to strengthen the existing warning regarding the risk of neuropsychiatric (NP) events and a modified indication to limit use for allergic rhinitis (AR), whi Mar 4, 2020 · FDA is strengthening existing warnings about serious behavior and mood-related changes with montelukast (Singulair and generics), which is a prescription medicine for asthma and allergy. It is a prescription medicine FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug Jan 9, 2024 · The Food and Drug Administration added a boxed warning to Singulair in 2020

2024-03-29
    Erythromycin induced rash
  1. Only take montelukast for hay
  2. G
  3. The U
  4. S
  5. Read more here
  6. S
  7. Authors Pei Yee Tiew 1 , Karen Li Leng Tan, Mariko Siyue Koh